SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates GA Poland, IG Ovsyannikova, RB Kennedy The Lancet 396 (10262), 1595-1606, 2020 | 685 | 2020 |
Multiple roles for CD4+ T cells in anti‐tumor immune responses R Kennedy, E Celis Immunological reviews 222 (1), 129-144, 2008 | 621 | 2008 |
Immunosenescence and human vaccine immune responses SN Crooke, IG Ovsyannikova, GA Poland, RB Kennedy Immunity & ageing 16, 1-16, 2019 | 431 | 2019 |
Fine mapping causal variants with an approximate Bayesian method using marginal test statistics W Chen, BR Larrabee, IG Ovsyannikova, RB Kennedy, IH Haralambieva, ... Genetics 200 (3), 719-736, 2015 | 241 | 2015 |
The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity IG Ovsyannikova, IH Haralambieva, SN Crooke, GA Poland, RB Kennedy Immunological reviews 296 (1), 205-219, 2020 | 229 | 2020 |
Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade E Davila, R Kennedy, E Celis Cancer research 63 (12), 3281-3288, 2003 | 225 | 2003 |
Personalized vaccinology: a review GA Poland, IG Ovsyannikova, RB Kennedy Vaccine 36 (36), 5350-5357, 2018 | 186 | 2018 |
Development of vaccines against Zika virus GA Poland, RB Kennedy, IG Ovsyannikova, R Palacios, PL Ho, J Kalil The Lancet Infectious Diseases 18 (7), e211-e219, 2018 | 178 | 2018 |
SARS-CoV-2 vaccine development: current status GA Poland, IG Ovsyannikova, SN Crooke, RB Kennedy Mayo Clinic Proceedings 95 (10), 2172-2188, 2020 | 153 | 2020 |
Prevention of monkeypox with vaccines: a rapid review GA Poland, RB Kennedy, PK Tosh The Lancet Infectious Diseases 22 (12), e349-e358, 2022 | 152 | 2022 |
Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery? GA Poland, RB Kennedy, IG Ovsyannikova PLoS pathogens 7 (12), e1002344, 2011 | 137 | 2011 |
Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century GA Poland, RB Kennedy, BA McKinney, IG Ovsyannikova, ND Lambert, ... Seminars in immunology 25 (2), 89-103, 2013 | 128 | 2013 |
Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses HIPC-CHI Signatures Project Team, HIPC-I Consortium Science immunology 2 (14), eaal4656, 2017 | 127 | 2017 |
Systems biology approaches to new vaccine development AL Oberg, RB Kennedy, P Li, IG Ovsyannikova, GA Poland Current opinion in immunology 23 (3), 436-443, 2011 | 126 | 2011 |
The immunology of smallpox vaccines RB Kennedy, IG Ovsyannikova, RM Jacobson, GA Poland Current opinion in immunology 21 (3), 314-320, 2009 | 124 | 2009 |
Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function RL Giuntoli, J Lu, H Kobayashi, R Kennedy, E Celis Clinical cancer research 8 (3), 922-931, 2002 | 120 | 2002 |
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations C Pawlowski, A Puranik, H Bandi, AJ Venkatakrishnan, V Agarwal, ... Scientific reports 11 (1), 4741, 2021 | 118 | 2021 |
The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches IH Haralambieva, IG Ovsyannikova, VS Pankratz, RB Kennedy, ... Expert review of vaccines 12 (1), 57-70, 2013 | 117 | 2013 |
Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses SN Crooke, IG Ovsyannikova, GA Poland, RB Kennedy Experimental gerontology 124, 110632, 2019 | 113 | 2019 |
Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections GA Poland, IG Ovsyannikova, RB Kennedy, IH Haralambieva, ... Omics: a journal of integrative biology 15 (9), 625-636, 2011 | 113 | 2011 |